3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
6
Osteosarcoma
6
Neuroblastoma
6
Leukemia, Myeloid, Acute
6
Glioma
6
Rhabdoid Tumor
5
Neoplasm Metastasis
5
Lymphoma, Non-Hodgkin
5
Hepatoblastoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Multiple Myeloma
4
Medulloblastoma
4
Histiocytosis, Langerhans-Cell
4
Ependymoma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Sarcoma, Ewing
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Central Nervous System Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Mouth Neoplasms
2
Melanoma
2
Interventions
pembrolizumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Specimen Handling
1
STA 9090
1
SGN-LIV1A
1
Proton Therapy
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
X-Rays
×
30 days
×
Clear all
No trials found.